Abstract
The first synthesis of 2′-deoxy-2′-fluoro-4′- selenoarabinofuranosyl pyrimidines as potent anticancer agents was accomplished using the DAST fluorination as a key step. It was first revealed that selenium atom participated in the DAST fluorination of 4′-selenonucleosides and that conformational bias induced by bulky selenium acted as a decisive factor in the DAST fluorination. Among compounds tested, 2′-F-4′-seleno-ara-C (4a) exhibited highly potent anticancer activity in all cancer cell lines tested and was more potent than ara-C (1).
Original language | English |
---|---|
Pages (from-to) | 5303-5306 |
Number of pages | 4 |
Journal | Journal of Medicinal Chemistry |
Volume | 52 |
Issue number | 17 |
DOIs | |
State | Published - 10 Sep 2009 |